HRT FINANCIAL LP - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q2 2023$8,119
+119.6%
11,300
+151.1%
0.08%
+68.9%
Q1 2023$3,697
-99.1%
4,500
+542.9%
0.04%
+800.0%
Q2 2022$413,000
-73.7%
700
-73.1%
0.01%
-50.0%
Q3 2021$1,573,000
-51.8%
2,600
-62.3%
0.01%
-69.7%
Q1 2021$3,264,000
+71.5%
6,900
+102.9%
0.03%
-40.0%
Q3 2020$1,903,000
+88.4%
3,400
+36.0%
0.06%
-65.0%
Q3 2018$1,010,0002,5000.16%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q1 2021
NameSharesValueWeighting ↓
Garda Capital Partners LP 3,500$2,880,3600.13%
Allianz Asset Management GmbH 31,500$25,923,2400.04%
SIMPLEX TRADING, LLC 64,400$52,9980.04%
JANE STREET GROUP, LLC 47,900$39,419,7840.01%
IMC-Chicago, LLC 16,500$13,578,8400.01%
GROUP ONE TRADING, L.P. 2,600$2,139,6960.01%
SG Americas Securities, LLC 23,600$3160.00%
Maven Securities LTD 400$329,1840.00%
JPMORGAN CHASE & CO 26,500$21,808,4400.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders